Targeted therapy in respiratory disease
Brian D. Kent
Breathe, 17 (4) 210170; 10.1183/20734735.0170-2021 |    |
The COVID-19 surge in Indonesia: what we learned and what to expect
Eric Daniel Tenda, Moses Mazmur Asaf, Ariel Pradipta, Meutia Ayuputeri Kumaheri, Anindya Pradipta Susanto
Breathe, 17 (4) 210146; 10.1183/20734735.0146-2021 | |
Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating
Jessica Denning, Jenny Negus, Niamh Cullen
Breathe, 17 (4) 210145; 10.1183/20734735.0145-2021 | |
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha
Breathe, 17 (4) 210110; 10.1183/20734735.0110-2021 | |
A pragmatic guide to choosing biologic therapies in severe asthma
Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson
Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 | |
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Daniel H. Tewkesbury, Rebecca C. Robey, Peter J. Barry
Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021 | |
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald
Breathe, 17 (4) 210118; 10.1183/20734735.0118-2021 | |
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy
Gokul Erumbala, Sabu Anzar, Amjad Tonbari, Ramadan Salem, Colin Powell
Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 | |
Precision medicine in bronchiectasis
Thomas Pembridge, James D. Chalmers
Breathe, 17 (4) 210119; 10.1183/20734735.0119-2021 | |
In pursuit of the primary
Jane Mendonca, Vishak Acharya, Sanyo D'souza, Kausalya Kumari Sahu, Sindhu Kamath, Jyoti R. Kini
Breathe, 17 (4) 210142; 10.1183/20734735.0142-2021 | |
A young man with transitory hemiparesis and lung infiltrates
Anja Ljilja, Niko Radovic, Jasna Tekavec-Trkanjec
Breathe, 17 (4) 210069; 10.1183/20734735.0069-2021 | |
First report of a very rare complication in a case of nonsmall cell lung carcinoma
Inês Moreira, Ana Sofia Vilariça, Paula Alves
Breathe, 17 (4) 210107; 10.1183/20734735.0107-2021 | |
A case of haemoptysis and bilateral areas of lung consolidation sparing the right lower lobe
Nadia Corcione, Antonio Ponticiello, Severo Campione, Alfonso Pecoraro, Livio Moccia, Giuseppe Failla
Breathe, 17 (4) 210072; 10.1183/20734735.0072-2021 | |
Syncope: a complication of chronic cough
Jenny King, Sarah Hennessey, James Wingfield Digby, Jaclyn Ann Smith, Paul Marsden
Breathe, 17 (4) 210094; 10.1183/20734735.0094-2021 | |
ERS ECM Awardee 2021, a preview of LSC 2022 and a brief overview of the Respiratory Channel
João C. Costa, Philip Mitchelmore, Niki D. Ubags, Cristina Calarasu, Holly R. Keir, Joana Cruz
Breathe, 17 (4) 210121; 10.1183/20734735.0121-2021 | |
Contribution of causal factors to disease burden: how to interpret attributable fractions
Emilie Counil
Breathe, 17 (4) 210086; 10.1183/20734735.0086-2021 | |
Lung cancer screening by volume computed tomography: thriving to high performance
Eline Schillebeeckx, Kevin Lamote
Breathe, 17 (4) 210063; 10.1183/20734735.0063-2021 | |
Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
Melissa J. McDonnell, Michael Harrison, Robert M. Rutherford
Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021 | |
Choosing pharmacotherapy for ILD in patients with connective tissue disease
Zhe Wu, Philip L. Molyneaux
Breathe, 17 (4) 210114; 10.1183/20734735.0114-2021 | |
Breathe, list of peer reviewers 2021
Breathe, 17 (4) 211741; 10.1183/20734735.1741-2021 | |